YU Xiuxia, CAO Xiaoming. Correlation between Helicobacter pylori infection and immune thrombocytopenia[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 108-110. DOI: 10.7619/jcmp.202002031
Citation: YU Xiuxia, CAO Xiaoming. Correlation between Helicobacter pylori infection and immune thrombocytopenia[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 108-110. DOI: 10.7619/jcmp.202002031

Correlation between Helicobacter pylori infection and immune thrombocytopenia

More Information
  • Received Date: October 12, 2019
  • Available Online: August 26, 2020
  • Published Date: August 26, 2020
  • Objective To investigate the correlation between Helicobacter pylori infection and immune thrombocytopenia. Methods A total of 112 patients with newly diagnosed as immune thrombocytopenia admitted to our hospital were enrolled in observation group. Another 112 healthy subjects were selected as control group during the same period. According to the results of treatment, the Helicobacter pylori-positive patients(n=42)in the observation group were further divided into radical treatment group and non-radical treatment group. Treatment effects and recurrence of radical treatment group and non-radical treatment group were statistically compared. And the conditions of Helicobacter pylori infection in control group and observation group were analyzed. Results The positive rate of Helicobacter pylori infection in the observation was significantly higher than that in the control group(37.50% vs. 21.43%, P<0.05). In terms of treatment effect, the radical treatment group was slightly higher than the non-radical treatment group, but the difference was not statistically significant(80.95% vs. 76.19%, P>0.05); the radical group was significantly lower in recurrence rate than the non-radical treatment group(14.29% vs. 38.10%, P<0.05). Conclusion There is a certain correlation between Helicobacter pylori infection and immune thrombocytopenia. However, in the newly diagnosed patients with immune thrombocytopenia, Helicobacter pylori infection is not the main pathogenic factor, so Helicobacter pylori radical treatment has little effect on early efficacy, but can reduce the recurrence of immune thrombocytopenia.
  • 王静, 郝国平, 王晓欢, 等. 幽门螺杆菌感染与3岁以上初诊患者免疫性血小板减少症的相关性分析[J]. 中国药物与临床, 2018, 18(7): 1193-1195.
    田雨英, 王颖. 幽门螺杆菌感染检测在患者免疫性血小板减少症诊治中的临床价值[J]. 中国实用医药, 2018, 13(17): 96-97.
    王浩澜, 刘宝山. 免疫性血小板减少性紫癜动物模型建立的研究进展[J]. 中国实验血液学杂志, 2018, 26(1): 273-277.
    赵殿凤, 张永峰. 联合抗幽门螺杆菌治疗原发免疫性血小板减少症[J]. 中外女性健康研究, 2018(7): 140, 149.
    徐丹. 根除幽门杆菌在原发免疫性血小板减少症中的应用进展[J]. 中外女性健康研究, 2019(7): 123, 192.
    张永卓. 幽门螺旋杆菌感染与儿童急性免疫性血小板减少性紫癜关系的临床观察[J]. 包头医学院学报, 2015, 31(7): 58-59.
    张晓燕, 白涛敏, 刘春风, 等. 免疫性血小板减少症儿童IgE水平变化分析[J]. 儿科药学杂志, 2017, 23(10): 4-6.
    黄南, 李文静, 赵炎, 等. 升阳益肾汤对肺肾阳虚型过敏性鼻炎患者免疫球蛋白lgE, lgM, lgA及淋巴细胞表达的影响[J]. 世界中医药, 2019, 14(7): 1771-1774

    , 1779.
    陈圣玺, 陈萍, 马世权. 奥美拉唑联合阿莫西林、甲硝唑在治疗幽门螺杆菌感染免疫性血小板减少症中的疗效观察[J]. 中国合理用药探索, 2017, 14(10): 51-53.
    徐丹, 郭少勇, 计成阜, 等. 儿童原发免疫性血小板减少症伴幽门螺杆菌感染的研究[J]. 血栓与止血学, 2017, 23(4): 556-557

    , 561.
    赵会娟. 血小板参数指标对儿童血小板减少症病因分析的价值[J]. 实用医技杂志, 2019, 26(7): 854-856.
    余强. 血小板参数指标对儿童血小板减少症病因分析的价值[J]. 实用检验医师杂志, 2017, 9(4): 217-219.
    苏鹏. 幽门螺杆菌感染与免疫性血小板减少症相关性研究进展[J]. 临床医药文献电子杂志, 2017, 4(43): 8510-8512.
    雷章花, 钱铃. 幽门螺杆菌感染对学龄前儿童免疫及生长发育状态的影响[J]. 中国妇幼保健, 2019, 34(1): 119-121.
    周亚方, 陶洁. 根除幽门螺杆菌在原发免疫性血小板减少症中的应用进展[J]. 中华临床医师杂志(电子版), 2017, 11(1): 132-135.
    杨金乐, 王庆海, 徐瑾, 等. 不同剂量丙种球蛋白与rhTPO治疗难治性血小板减少性紫癜的免疫学及氧化应激反应比较[J]. 河北医药, 2019, 41(16): 2469-2472.
    蔡键玲, 吴北燕. 幽门螺杆菌感染与儿童免疫性血小板减少症免疫紊乱的关系[J]. 医学综述, 2016, 22(14): 2837-2839.
    雷章花, 钱铃. 幽门螺杆菌感染对学龄前儿童免疫及生长发育状态的影响[J]. 中国妇幼保健, 2019, 34(1): 119-121.
  • Cited by

    Periodical cited type(2)

    1. 赖奇琨,文强,冷周江才,付曦文,唐明虎. 基于STC单片机糖尿病足压力缓解装置的设计. 黑龙江科学. 2025(06): 52-56 .
    2. 李钰,林玲霞,苏媛媛,袁刚. 新型压力监测设备在导尿患者膀胱锻炼的应用. 医学研究杂志. 2021(01): 119-123 .

    Other cited types(1)

Catalog

    Article views (407) PDF downloads (8) Cited by(3)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return